Cargando…
Second‐line immunotherapy and functional outcomes in autoimmune encephalitis: A systematic review and individual patient data meta‐analysis
Autoimmune encephalitis (AE) is a neurological disorder caused by autoimmune attack on cerebral proteins. Experts currently recommend staged immunotherapeutic management, with first‐line immunotherapy followed by second‐line immunotherapy if response to first‐line therapy is inadequate. Meta‐analysi...
Autores principales: | Halliday, Amy, Duncan, Andrew, Cheung, Mike, Boston, Ray C., Apiwattanakul, Metha, Camacho, Ximena, Bowden, Stephen, D'Souza, Wendyl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796249/ https://www.ncbi.nlm.nih.gov/pubmed/35700069 http://dx.doi.org/10.1111/epi.17327 |
Ejemplares similares
-
Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium
por: Broadley, James, et al.
Publicado: (2021) -
Characteristics of Epileptiform Discharge Duration and Interdischarge Interval in Genetic Generalized Epilepsies
por: Seneviratne, Udaya, et al.
Publicado: (2018) -
Immunotherapy for Refractory Autoimmune Encephalitis
por: Yang, Jiawei, et al.
Publicado: (2021) -
COMMON PRESENTATION WITH AN UNCOMMON ETIOLOGY: THYMOMA-ASSOCIATED AUTOIMMUNE ENCEPHALITIS INDUCED BY COVID-19 BOOSTER VACCINE
por: ILAGAN, JUSTIN, et al.
Publicado: (2022) -
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2022)